薬理系11/薬理系14/医薬品毒性学/臨床医学総論/薬理学実習/新薬概論

主な研究テーマ

糖尿病治療薬であるインクレチン関連薬の脂質代謝、骨代謝に与える効果

研究論文

Saito M, Onodera M, Sato Y, Kumagai F, Eto M. Beneficial effects of fenofibrate on triglyceride-rich lipoproteins-loaded osteoblasts. Jpn Pharmacol Ther 50: 2151-2156, 2022

Saito M, Kumagai F, Murai F, Ishimoto A, Sato Y, Eto M. Effects of glucose-dependent insulinotropic polypeptide (GIP) on RANKL and Type 1 collagen in triglyceride-rich lipoproteins-loaded osteoblasts. Jpn Pharmacol Ther 50: 1957-1962, 2022

Kumagai F, Saito M, Takigami S, Eto M.  Effects of apolipoprotein E4 allele on plasma LDL cholesterol response to ezetimibe monotherapy in hypercholesterolemic patients. Jpn Pharmacol Ther 47: 1387-1392, 2019

Saito M, Kumagai F, Takigami S, Eto M.  Effects of pemafibrates on plasma lipids and renal function in aged patients with hypertriglyceridemia. Jpn Pharmacol Ther 46: 1979-1983, 2018

Kumagai F, Saito M, Eto M.  Incretin suppreses the synthesis of apolipoprotein B 48 in the small intestine. Jpn Pharmacol Ther 46: 1659-1663, 2018

Saito M, Kumagai F, Tsuchiya H, Takigami S, Eto M. Osteopenia in type 2 diabetic patients and effects of denosumab on diabetic osteopenia. jpn Pharmacol Ther 44: 1157-1164, 2016

Saito M, Kumagai F, Igarashi M, Takigami S, Eto M.  Effects of sitagliptin on plasma remnant cholesterol and urinary albumin in diabetic patients with apo E2 allele. Jpn Pharmacol Ther 43: 1577-1583, 2015

日本薬学会

日本薬学教育学会

日本骨粗鬆症学会